Steroid Cell Tumor of the Ovary (Not Otherwise Specified Subtype) - A Rare Case Report

January 2017 in “ University journal of surgery and surgical specialities ”

Deepapriya Deepapriya

steroid cell tumor ovarian tumor estrogen testosterone cortisol androgenic symptoms estrogenic symptoms virilizing ovarian tumor hormonal monitoring hormone-producing tumor increased body hair balding elevated testosterone

TLDR Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Ovarian steroid cell tumors, particularly the "not otherwise specified" (NOS) subtype, were rare, comprising only 0.1% of all ovarian tumors. These tumors were known for producing hormones like estrogen, testosterone, and cortisol, and were most common in perimenopausal and postmenopausal women, sometimes causing androgenic and estrogenic symptoms. The case report detailed a 42-year-old woman with increased body hair and balding, who was found to have a 5.5 cm mass in her left ovary. Her elevated testosterone levels led to a diagnosis of a virilizing ovarian tumor, confirmed as a steroid cell tumor (NOS) after surgery. These tumors had a 40% potential for malignancy, necessitating thorough surgical staging and regular hormonal monitoring.

View this study on ejournal-tnmgrmu.ac.in →

Discuss this study in the Community →

Related Community Posts Join

6 / 706 results

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 830 upvotes 1 year ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Hair loss research is a money grab

in Chat 217 upvotes 6 days ago

Hair loss is linked to DHT, with treatments like finasteride and minoxidil being common but not definitive. Economic interests influence research, and there is potential for new treatments like PP405 and RU58841.

Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

community Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

in Research 865 upvotes 1 year ago

The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

community Why isn't anyone using Way-316606? If it works then it grows a full head of hair back on most people

in Treatment 134 upvotes 8 months ago

Way-316606 is considered a potential hair loss treatment but is avoided due to safety concerns and lack of research. Minoxidil and Finasteride are preferred as established treatments.

community Expectations control for SCUBE3

in Research/Science 21 upvotes 1 year ago

SCUBE3, a protein linked to hair growth in moles, was discovered over 25 years ago and is being developed by Amplifica for potential hair loss treatment. Concerns exist about SCUBE3's association with cancer, as it is a protein that promotes cell growth, which could potentially trigger cancer development if used for hair growth therapy.

community Is There Any Chance Of Cancer In Follicle Neogenesis through Microneedling?

in Microneedling 17 upvotes 5 years ago

The conversation discusses concerns about the potential risk of cancer from creating new hair follicles through microneedling, due to stem cell division. Specific treatments mentioned include microneedling, caffeine-containing anti-hair loss shampoos, and other unspecified topicals.

Related Research

2 / 2 results

research A Rare Case of Steroid Cell Tumor, Not Otherwise Specified, of the Ovary in a Young Woman

3 citations , July 2019 in “Case Reports in Obstetrics and Gynecology”

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

research An Unusual Circulating Steroid Profile in a Virilized Postmenopausal Woman

2 citations , May 2018 in “Diagnosis”

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.